INTERNATIONAL PATENT: FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR), FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA (IRB) FILES APPLICATION FOR "SMALL MOLECULE INHIBITOR OF FOXA1 AND FOXA2 FOR THE TREATMENT OF FOXA1/FOXA2-DEPENDENT CANCERS OR OTHER DISEASES"

GENEVA, May 4 -- FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) (Via Francesco Chiesa 56500 Bellinzona), FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA (IRB) (Via Francesco Chiesa 56500 Bellinzona) filed a patent application (PCT/IB2025/060672) for "SMALL MOLECULE INHIBITOR OF FOXA1 AND FOXA2 FOR THE TREATMENT OF FOXA1/FOXA2-DEPENDENT CANCERS OR OTHER DISEASES" on Oct 20, 2025. With publication no. WO/2026/088050, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): THEURILLAT, Jean-Philippe (Via Rinaldo Simen 8166...